Internal Medicine, Infectious Disease · Tampa, FL
NPI
1306145164
Since 2011
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4729 N Habana Ave
Tampa, FL, 33614
Phone (813) 251-8444
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
113,769 services
Medicare patients, 2024
598
Average age 72
Drug cost, 2024
$2.8M
2,283 prescriptions
Company payments, 2025
$1,895
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meghan M Harris was code 99232 (hospital e&m - subsequent), 560 times for 232 patients. In total Meghan M Harris billed 113,769 services in 53 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 560 | 232 | $60.07 | $34K |
| 96365 Intravenous Infusion, Hydration | Office | 431 | 33 | $46.25 | $20K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 366 | 16 | $8.95 | $3,274 |
| 99231 Hospital E&M - Subsequent | Facility | 248 | 176 | $37.96 | $9,413 |
| 99214 Office E&M - Established | Office | 152 | 116 | $91.34 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 127 | 91 | $12.79 | $1,624 |
| 99233 Hospital E&M - Subsequent | Facility | 120 | 64 | $90.27 | $11K |
| 99222 Hospital E&M - Initial | Facility | 116 | 113 | $99.45 | $12K |
| 99215 Office E&M - Established | Office | 69 | 41 | $134.94 | $9,311 |
| 99204 Office E&M - New | Office | 43 | 43 | $122.26 | $5,257 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 42 | 41 | $79.20 | $3,326 |
| 99223 Hospital E&M - Initial | Facility | 41 | 41 | $133.46 | $5,472 |
| 36415 Venipuncture Blood Collection | Office | 40 | 30 | $8.44 | $338 |
| 99205 Office E&M - New | Office | 19 | 19 | $153.38 | $2,914 |
| 99221 Hospital E&M - Initial | Facility | 19 | 19 | $58.50 | $1,111 |
By year: 2022 $196K for 101,938 services; 2023 $145K for 47,726 services; 2024 $165K for 113,769 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 40 | 30 | $8.44 | $338 |
Medicare prescription drug claims, 2024
In 2024, the drug Meghan M Harris prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 156 prescriptions and refills. In total Meghan M Harris wrote 2,283 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 156 | 156 | 27 | $631K |
| Vancomycin Hcl Generic | 122 | 124 | 28 | $19K |
| Doxycycline Hyclate Generic | 111 | 194 | 53 | $3,962 |
| Dovato Dolutegravir Sodium/Lamivudine | 91 | 97 | Under 11 | $274K |
| Azithromycin Generic | 79 | 104 | 15 | $2,354 |
| Cephalexin Generic | 73 | 99 | 29 | $1,844 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 66 | 80 | 16 | $1,207 |
| Cefepime Hcl Generic | 64 | 64 | 18 | $8,100 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 76 | 23 | $508 |
| Tivicay Dolutegravir Sodium | 49 | 51 | Under 11 | $143K |
| Ciprofloxacin Hcl Generic | 49 | 61 | 26 | $696 |
| Ceftriaxone Ceftriaxone Sodium | 47 | 47 | 12 | $2,422 |
| Fluconazole Generic | 46 | 70 | 33 | $1,685 |
| Isoniazid Generic | 43 | 63 | 11 | $416 |
| Meropenem Generic | 43 | 43 | Under 11 | $6,861 |
Brand drugs: 697 claims; generic drugs: 1,586 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meghan M Harris $1,895 ($1,895 in general payments such as food, travel and fees) from 16 companies. The largest payer was ViiV Healthcare Company with $464.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 17 | $464 |
| Astellas Pharma US Inc 4503.T | 7 | $285 |
| Insmed, Inc. INSM | 10 | $222 |
| Gilead Sciences, Inc. GILD | 8 | $186 |
| Shionogi Inc 4507.T | 7 | $181 |
| Merck Sharp & Dohme LLC MRK | 9 | $162 |
| Theratechnologies Inc. THTX | 4 | $110 |
| CSL Behring CSL.AX | 3 | $72.69 |
| Abbvie Inc. ABBV | 2 | $49.58 |
| Electromed, Inc. ELMD | 3 | $40.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.